With Vioxx , researchers had been warning about the drug 's possible cardiovascular risks since 2000 , only a year after it was approved by the FDA .The FDA said last week after Vioxx was withdrawn that the problems were unique to that drug .`` Neither Merck nor the FDA fulfilled its responsibilities to the public ...The FDA 's own study of the Vioxx safety issue has become mired in controversy .By contrast , Vioxx made $ 2.5 billion for Merck last year .